Categories: Health

Transactions under Novonesis share buyback program

Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.

Please read the full announcement in PDF.

Attachment

GlobeNews Wire

Recent Posts

Gastops Delivers 20,000th MetalSCAN Sensor to the Aerospace Market

OTTAWA, ON, July 21, 2026 /PRNewswire/ - Gastops, a Canadian leader in intelligent condition monitoring and…

17 minutes ago

OptiMIM Announces Official Opening of OptiMIM Global Manufacturing Facility in India

New facility strengthens global manufacturing capabilities through the strategic joint venture between OptiMIM and Vasantha…

17 minutes ago

Aberystwyth University launches new education partnership

LONDON, July 21, 2026 /PRNewswire/ -- Aberystwyth University has launched a new educational partnership with…

17 minutes ago

Formal Statement by Jingye Steel Co., Ltd.

SHIJIAZHUANG, China, July 21, 2026 /PRNewswire/ -- In relation to the UK Government's compulsory nationalisation of…

17 minutes ago

Apollo Hospitals Brings Next-Generation Lysin Science to India’s Fight Against AMR – Collaborates with Precisio Biotix

HYDERABAD, India, July 21, 2026 /PRNewswire/ -- Apollo Hospitals today announced a strategic collaboration with Precisio Biotix…

17 minutes ago

CARD91 offers its comprehensive PPI Suite to Indian Overseas Bank with RuPay NCMC Capability

Built on NPCI's National Common Mobility Card framework, the partnership widens Indian Overseas Bank's product…

2 hours ago